YTHL Financials 07/18/2014 21:40:50
YTHL Financials 07/18/2014 21:40:50
Yingtui Holdings Ltd.
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Research and Development
Sales, General and Admin.
Non-Recurring Items
Other
Operating Income
Income From Continuing Operations
Add'l Income/Expense Items
Earnings Before Interest and Tax
Interest Expense
Earnings Before Tax
Income Tax
Minority Interest
Equity Earnings Unconsolidated Subsidiary
Net Income Cont. Operations
Non Recurring Events
Discontinued Operations
Extraordinary Items
Effect of Accounting Changes
Other Items
Net Income
Preferred Stock and Other Adjustments
Net Income Applicable to Common Shareholders
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Deciphering the Homeowners Insurance Jigsaw The modern homeowner doesn't just contend with maintenance and mortgage payments, but also with the labyrinth of insurance policies that promise to shield their homes against calamity. But when the chips are down, is filing an insurance claim always the right call? Sara Turgeon, the insurance maven from Pickens, SC, sheds light...
Continue Reading
A Journey Spanning Four Decades A poetry collection tracing personal and emotional epiphanies—now there's something more gripping than any stock ticker. Kelly Michelle Long's 'Finding Yourself Once Again' packages four decades of pen to paper in a book that’s a tapestry of heartfelt stories and reflections. It's personal but relatable, casting a light on those intense...
Continue Reading
KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...
Continue Reading
NextVision's financials this quarter are the envy of tech growth companies everywhere. Their Q3 2026 report reads like a thrilling playbook for success. No half-measures here—NextVision has doubled its revenue, slashed costs, and cooked up an operating margin fit for a kingpin. Pushing Revenue to New Heights NextVision didn’t just surpass last year's revenue; it...
Continue Reading
Illinois Cranks Up the Heat on Low-Dose THC Drinks Illinois, you've really done it this time. When it comes to low-dose THC beverages, the state is setting up shop for illicit sellers by going harsher than federal standards. On November 12, these drinks, which have a loyal following, will be off the shelves—thanks to a reclassification that lumps them in with more...
Continue Reading
Pioneering Transformation in Infrastructure Management Ever felt like infrastructure management's been stuck in the stone age? Well, Houston's own ABYSS just kicked that notion to the curb. Formerly Abyss Solutions, they're relaunching themselves with a new mission that might just set the industry on fire. They're calling it the Asset Operating Environment, and trust me,...
Continue Reading
San Diego's Seasonal Giving: A Community Effort Hold onto your hats, folks—it's that time of the year when giving isn't just a suggestion; it's a full-fledged community rallying cry. Heading into the joyful chaos is North Island Credit Union, teaming up with Boys & Girls Clubs of Greater San Diego to bring the spirit of the season to children across the region. Through...
Continue Reading
An Unexpected Turn in the Drug Discovery Arena It's not every day that you see a historic French pharma powerhouse and a cutting-edge Chinese tech firm join forces. On one side, we've got Laboratoires Pierre Fabre, steeped in the history and nitty-gritty of clinical drug development. On the other, we’ve got XtalPi Holdings Limited (2228.HK), bringing their high-tech AI...
Continue Reading
Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...
Continue Reading
A Glimmer of Hope for Gout Sufferers Uncontrolled gout patients may soon see a light at the end of the tunnel. Protalix BioTherapeutics (NYSE American: PLX) just rolled out data at the ACR Convergence 2026, underscoring the potential of their drug candidate, PRX-115. This revelation is a big deal for those grappling with gout that just won't quit, constantly pelted by...
Continue Reading
Top 5 Most Recently Viewed Articles
Invivyd's Upcoming Financial Results Conference Call Invivyd, Inc. (Nasdaq: IVVD), a pioneering leader in the biopharmaceutical industry, has exciting developments lined up for their investors. On an upcoming Thursday morning, the company will host a conference call aimed at discussing their financial performance and business strategies. This communication will take place...
Continue Reading
The emergence of young Chinese artists reshaped the cultural scene by fusing traditional elements with contemporary expressions. This isn’t just a passing phase; it’s a full-blown movement where the youth aren’t merely adopting global trends but redefining them with their unique insights. Take Liu Qingyi, for example. The 19-year-old breakdancer dazzled audiences at...
Continue Reading
STRATA Skin Sciences to Attend D. Boral Capital Conference STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a prominent medical technology company, is set to participate in the D. Boral Capital Inaugural Global Conference. This significant event will be held in a leading location, offering the perfect platform for STRATA to showcase its...
Continue Reading
Medecision Partners with Sendero Health Plans for Health Improvement Medecision, a leader in clinical data solutions, has announced an exciting partnership with Sendero Health Plans, a nonprofit healthcare organization. Together, they aim to significantly enhance health outcomes within the communities of Central Texas. Commitment to Quality Care Sendero Health Plans is...
Continue Reading
Julia Vorholt's Groundbreaking Research Professor Julia Vorholt has made significant contributions to our understanding of plant health through her pioneering research on plant microbiomes. Her work reveals that just like humans rely on beneficial gut bacteria, plants too harbor communities of microorganisms that play a vital role in their development. This revelation...
Continue Reading